Laboratory test |
Patient |
Normal
Range |
Complete blood count |
Complete blood count |
Complete blood
count |
White blood cells (×103 cells/mm3) |
8.3 |
3.98-10.2 |
Neutrophils (%) |
66% |
- |
Lymphocytes (%) |
31% |
- |
MXD (%) |
3% |
- |
Hemoglobin (gr/dl) |
7.5 |
- |
Platelets (×103 cells/mm3) |
725 |
150-450 |
Lymphocytes subsets (% of lymphocytes) |
Lymphocytes subsets (% of
lymphocytes) |
Lymphocytes subsets (% of lymphocytes) |
CD3+ |
46.8% |
35-78 |
CD4+ |
31% |
22-62 |
CD8+ |
15% |
12-36 |
CD19+ |
33% |
3-14 |
CD16+ |
5.1% |
4.5-25 |
CD56+ |
5.1% |
5-29 |
CD4+/CD8+ ratio |
2.0 |
1.0-4.0 |
Serum immunoglobulins |
Serum immunoglobulins |
Serum
immunoglobulins |
IgG (g/L) |
15.6 |
7.0-16.0 |
IgM (g/L) |
1.0 |
0.4-2.3 |
IgA (g/L) |
0.9 |
0.4-3.9 |
IgE (IU/ml) |
85 |
<144 |
Specific antibodies |
Specific antibodies |
Specific
antibodies |
Anti-tetanus antibody (IU/ml) |
0.7 |
>0.1 |
Anti-diphtheria antibody (IU/ml) |
0.2 |
>0.01 |
Anti-A Isohemagglutinin |
1/32 |
|
Anti-B Isohemagglutinin |
1/16 |
|
Others |
Others |
Others |
NBT test (%) |
99 |
>95 |
PPD skin test |
Negative |
|
ESR |
81 |
0-22 |
CRP |
50 |
<10 |
Wright and Widal test |
Negative |
|
PCR for HIV |
Negative |
|
Gamma-GT |
Normal |
|
MXD; Mixed Cell Count, NBT; Nitro blue tetrazolium test,
PPD; purified protein derivative
|
MXD; Mixed Cell Count,
NBT; Nitro blue tetrazolium test, PPD; purified protein
derivative
|
MXD; Mixed Cell Count, NBT; Nitro blue
tetrazolium test, PPD; purified protein
derivative
|